Tolvaptan should be used very carefully in very elderly patients

References (2)

1. Zizza CA, Ellison KJ, Wernette CM. Total Water Intakes of Community-Living Middle-Old and Oldest-Old Adults. J Gerontol A Biol Sci Med Sci 2009; 64: 481-6. [CrossRef] Sağ S, Aydın Kaderli A, Yıldız A, Gül BC, Özdemir B, Baran İ, et al. Use of tolvaptan in patients hospitalized for worsening chronic heart failure with severe hyponatremia: The initial experience at a single-center in Turkey. Turk Kardiyol Dern Ars 2017; 45: 415-25.
2. Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007; 297: 1319-31. [CrossRef] Ndrepepa G. Tolvaptan in the very elderly with acute decompensated heart failure- a therapeutic option worth of consideration. Anatol J Cardiol 2017; 18: 213-4. Niikura H, lijima R, Anzai H, Kogame N, Fukui R, Takenaka H, et al. The clinical utility of early use of tolvaptan in very elderly patients with acute decompensated heart failure. Anatol J Cardiol 2017; 18: 206-12. [CrossRef]